Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 17:14:1248435.
doi: 10.3389/fgene.2023.1248435. eCollection 2023.

Editorial: Rare dyslipidemias

Fouzia Sadiq  1 , Robert A Hegele  2 , Alberico L Catapano  3   4 , Urh Groselj  5   6
Affiliations
Editorial

Editorial: Rare dyslipidemias

Fouzia Sadiq et al. Front Genet. .
No abstract available

Keywords: atherosclerosis; cardiovascular disease; dyslipidemia; familial hypercholesterolemia; rare diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Rare dyslipidemias

References

    1. Bea A. M., Cenarro A., Marco-Bened V., Laclaustra M., Martn C., Ibarretxe D., et al. (2023). Diagnosis of familial dysbetalipoproteinemia based on the lipid abnormalities driven by APOE2/E2 genotype. Clin. Chem. 69 (2), 140–148. 10.1093/clinchem/hvac213 - DOI - PubMed
    1. Berberich A. J., Hegele R. A. (2022). A modern approach to dyslipidemia. Endocr. Rev. 43 (4), 611–653. 10.1210/endrev/bnab037 - DOI - PMC - PubMed
    1. Cuchel M., Raal F. J., Hegele R. A., Al-Rasadi K., Arca M., Averna M., et al. (2023). Update on European atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: New treatments and clinical guidance. Eur. Heart J. 44 (25), 1–15. 10.1093/eurheartj/ehad197/7148157 - DOI - PMC - PubMed
    1. D’Erasmo L., Bini S., Arca M. (2021). Rare treatments for rare dyslipidemias: New perspectives in the treatment of homozygous familial hypercholesterolemia (HoFH) and familial chylomicronemia syndrome (FCS). Curr. Atheroscler. Rep. 23 (11), 65. 10.1007/s11883-021-00967-8 - DOI - PMC - PubMed
    1. D’Erasmo L., Di Costanzo A., Cassandra F., Minicocci I., Polito L., Montali A., et al. (2019). Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes. Arterioscler. Thromb. Vasc. Biol. 39 (12), 2531–2541. 10.1161/ATVBAHA.119.313401 - DOI - PubMed

Publication types

LinkOut - more resources